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Laparoscopic approaches are increasingly used in pancreatic
surgery. In the treatment of neuroendocrine tumors (NETs) of
the pancreas, enucleation is one of the recommended surgery.
Although many clinical experiences have reported the safety
and efficacy of laparoscopic enucleation of functioning NETs,
such as insulinomas, few reports have explored such treatment
for non-functioning NETs. Here, we present a case of 70-year
old female patient who underwent successful laparoscopic
enucleation of a nonfunctioning NET located in the body of
the pancreas.
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INTRODUCTION
Laparoscopic approaches are increasingly used in
pancreatic surgery, and have been extended to use
in the staging of malignant pancreatic neoplasms,
the management of benign inflammatory pancreatic
disease, and the resection of benign or borderline
malignant cysts and neoplasms of the pancreas.
1-5 In
the treatment of neuroendocrine tumors (NETs) of
the pancreas, enucleation is the recommended
surgery, since the tumors are usually benign and
pancreatic function must be preserved. Although
many researches have described the safety and
efficacy of laparoscopic enucleation of functioning
NETs, such as insulinomas,
5-10 few reports on such
treatment for non-functioning NETs of the
pancreas have been introduced. Here, we present
a case of successful laparoscopic enucleation of a




A 70-year-old female patient was admitted to the
Department of Surgery at Yonsei Medical Center in
Seoul, Korea after a pancreatic mass was
incidentally discovered during the evaluation of
abdominal discomfort and nausea. She had
previously been in good health without any prior
medical history. An abdominal CT scan revealed a
1 cm-sized hypervascular mass in the body of the
pancreas without any evidence of regional lymph
node enlargement or distant metastasis (Fig. 1). An
endoscopic ultrasound of the entire pancreas
revealed a single 1 cm-sized homogenous, hypo-
echoic mass in the pancreatic body (Fig. 2) Routine
blood chemistry and tumor marker levels (CA 19-9,
CEA, and CA 125) were all within normal limits.
Because it appeared that the patient had a
neuroendocrine tumor of the pancreas, she under-
went laparoscopic enucleation.
Surgery
The patient was placed in the supine position
with her legs separated. The surgeon and scrub
nurse stood on the right side of the patient, the
assistant surgeon navigated the camera and stood
between the patient’s legs, while another assistant
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surgeon stood on the left side of the patient. A
total of four trocars (one 12-mm trocar, three
5-mm trocars) were used in this surgical proce-
dure (Fig. 3). Two trocars (5-mm) were placed on
the right side to pass the instruments, and another
trocar (5-mm) was inserted on the left side to
retract the lateral segment of the liver. Two
monitors, a 30 degree laparoscope, a harmonic
scalpel and routine laparoscopic instruments were
used, and CO2 pneumoperitoneum (12 mmHg)
was maintained throughout the procedure.
Initially, the hepatogastric ligament was opened
and the pancreatic mass was easily identified. It
was superficial and well-demarcated pancreatic
mass (Fig. 4A). The entire pancreas was explored
with a flexible laparoscopic ultrasound and the
lesion was detected at the site previously indi-
cated by CT and EUS. One prolene 5-0 holding
suture was placed through the pancreatic mass for
appropriate traction. Enucleation of the pancreatic
mass was achieved by blunt and sharp dissection
of the peripancreatic tissue (Figs. 4B and C). After
completion of the surgical procedure, the pan-
creatic mass was withdrawn from the abdominal
cavity with a plastic bag. The surgical procedure
was completed without requiring any abdominal
drain.
Postoperative course
The patient recovered without complication.
She returned to an oral diet immediately and was
discharged on the third postoperative day. Patho
Table 1. Literature Review of Nonfunctioning Neuroendocrine Tumors of the Pancreas Treated by Laparoscopic Enucleation
Author Age (yrs) Sex Size Location Op. time (min) Blood loss (mL) Complication LOS
Pierce RA, et al.
14 66 M 0.8 Tail 259 20 None 3
Singh N, et al.
13 26 F 5 Head 165 50 None 3
Current case 70 F 1 Body 60 10 None 3
M, male; F, female.
Fig. 1. Abdominal CT scan. About 1 cm-sized enhanced
mass is noted in the surface of the pancreatic body.
Fig. 2. Endoscopoic Ultrasonogram. About 1 cm-sized,
single, homogenous, hypoechoic mass was found in the
pancreatic body.
Fig. 3. Trocar placement.Chang Moo Kang, et al.
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logic evaluation revealed the resected specimen
was found to be a 10 × 12 × 10 mm mass (Fig. 4D),
with the histological features of a pancreatic
endocrine tumor. The cells stained immunohi-
stochemically with chromogranin A (Figs. 5 and
6). It had no evidence of local invasiveness (no
neural invasion, no lymphovascular invasion, no
capsular /peripancreatic invasion). Especially, the
expression of Ki-67 was less than 5%.
Fig. 4. Intraoperative laparoscopic view. Superficial locating, well-demarcated pancreatic mass is noted in the
body of pancreas (A). Enucleation of the pancreatic mass is achieved (B and C). Gross pathologic finding. It
was about 1cm sized homogenous well demarcating mass (D).
Fig. 5. Hematoxylin-Eosin staining (× 200). Fig. 6. Immunohistochemstry with chromogranin A (× 200).
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DISCUSSION
Neuroendocrine (islet cell) tumor (NET) of the
pancreas is a relatively rare pathologic condition.
5
Most NETs of the pancreas are not associated with
the clinical symptoms of hormonal over-secretion
and are classified as nonfunctional.
Laparoscopic pancreatic surgery is emerging as
a treatment option for nonfunctioning NETs of the
pancreas. Based on our surgical experience with
nonfunctioning NETs,
11 53% of the patients had
tumors in distal part of the pancreas and the median
tumor size was 3.5 cm in diameter. Theoretically,
laparoscopic distal pancreatectomy can be
recommended for those neoplasms. However, in
our experience, tumors greater than 3 cm in
diameter were preoperative risk factors for an
increased rate of metastasis and macroinvasion to
adjacent organs, and substantially impacted patient
survival. Therefore, the laparoscopic approach
should be carefully chosen in large nonfunctioning
NETs because curative resection is so important for
long-term survival.
Laparoscopic distal pancreatectomy with or
without splenectomy has been reported in the
literature as a treatment for nonfunctioning NETs of
the pancreas,
1,5,12 but reports of laparoscopic
enucleation of nonfunctioning NETs of the pancreas
are rare. This relative paucity of data may be related
to the asymptomatic nature of these neoplasms. In
contrast, laparoscopic enucleation of functioning
NETs, such as insulinomas, has been frequently
described. The asymptomatic nature of small
nonfunctioning NETs is an obstacle to the early
discovery of such tumors. However, the frequency
of early detection of small lesions in the pancreas
is expected to increase due to easy accessibility of
abdominal ultrasound and increased patient
health awareness. With such early detection,
laparoscopic enucleation of small, nonfunctioning
NETs of the pancreas could offer a shorter
hospital stay, good cosmetic effect, less pain, and
an early return to normal social activity.
Only two cases of laparoscopic enucleation for
nonfunctioning pancreatic NETs have been
reported in the literature (Table 1).
13,14 In general,
nonfunctioning NETs in the pancreatic head are
not recommended for such surgery because of the
risk of open conversion due to technical
difficulties or an inability to localize the tumor.
15
However, successful laparoscopic enucleation of
such tumors has been reported, and this procedure
appears to be feasible and reproducible in well-
selected benign nonfunctioning NENs of the
pancreas.
Minimally invasive surgery is thought to both
reduce surgical damage and minimize the
frequency of postoperative complications. Enuclea-
tion procedures have the advantage of preserving
pancreatic and spleen parenchyma, without the
morbidity, mortality, or late sequelae of extensive
resection.
16 The most common complication is
pancreatic fistula.
17 Accordingly, patients may be
considered candidates for enucleation if the pancreatic
neoplasm is free of the pancreatic duct and has no
vascular involvement on preoperative imaging
studies. To this end, intraoperative ultrasound can
aid in identifying the mass and determining its
proximity to the pancreatic duct, which can
decrease the incidence of the pancreatic fistula.
18
In current case, we did not place any type of drain
system because the tumor was very small (about
1 cm) and superficial location apart from main
pancreatic duct, which may have low risk of
postoperative pancreatic fistula. We don’t think
any drainage sysment is necessary.
In summary, we avoided a long abdominal
incision and inflicted less stressful surgical
damage by laparoscopically treating the small,
nonfunctioning NET of this older patient.
Laparoscopic enucleation of well-selected non-
functioning NETs of the pancreas, such as a
single, small, benign pancreatic mass superficially
located in the pancreas, seems to be feasible.
However, long-term follow up is mandatory given
their likelihood of a more malignant course.
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